China Health EV/EBITDA
¿Qué es el EV/EBITDA de China Health?
El EV/EBITDA de China Health Group Inc. es 7.21
¿Cuál es la definición de EV/EBITDA?
EV / EBITDA es el valor de la empresa dividido por las ganancias antes de intereses, impuestos, depreciación y amortización. Es una medida de cuál cara es una acción y es más frecuentemente válida para comparaciones entre compañías que la relación precio / ganancias. Mide el precio (en forma de valor empresarial) que un inversionista paga en beneficio del flujo de caja de la compañía (en forma de EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA de compañías en Sector Health Care en HKSE en comparadas con China Health
¿Qué hace China Health?
China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
Empresas con ev/ebitda similar a China Health
- Bowl America tiene EV/EBITDA de 7.20
- Zhejiang Chang'an Renheng Technology Co tiene EV/EBITDA de 7.20
- Intense Technologies tiene EV/EBITDA de 7.20
- Zenitel NV tiene EV/EBITDA de 7.20
- Next Solar Fund tiene EV/EBITDA de 7.20
- DS Smith Plc tiene EV/EBITDA de 7.21
- China Health tiene EV/EBITDA de 7.21
- Bodal Chemicals tiene EV/EBITDA de 7.21
- V2X Inc tiene EV/EBITDA de 7.21
- Hertz Global tiene EV/EBITDA de 7.21
- Information Services tiene EV/EBITDA de 7.21
- Pathward Inc tiene EV/EBITDA de 7.21
- Impellam PLC tiene EV/EBITDA de 7.22